ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03672773
Brief Title: Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

First Submitted : August 14, 2018
First Submitted that Met QC Criteria : September 13, 2018
First Posted : September 14, 2018

Last Update Submitted that Met QC Criteria : October 12, 2018
Last Update Posted : October 16, 2018